查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1926909

醫療MIM組件市場按技術、實施類型、最終用戶、應用和分銷管道分類 - 全球預測（2026-2032年）

Medical MIM Component Market by Technology, Deployment Mode, End User, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫療 MIM 零件市場價值將達到 41.7 億美元，到 2026 年將成長至 44.4 億美元，到 2032 年將達到 64.6 億美元，年複合成長率為 6.45%。

關鍵市場統計數據
基準年 2025 41.7億美元
預計年份：2026年 44.4億美元
預測年份 2032 64.6億美元
複合年成長率 (%) 6.45%

本文簡要概述了醫療影像組件領域不斷發展的格局，並闡述了影響策略決策的臨床、技術和採購促進因素。

由於硬體設計、軟體分析和醫療服務模式的同步發展，醫學影像組件領域正經歷快速演變。本報告首先簡要概述當前環境，重點闡述了日益多樣化的成像方式、互通性以及不斷變化的終端用戶需求如何共同重塑採購和臨床工作流程。透過向讀者提供這一動態背景，我們闡明了對實施和投資決策影響最大的技術和營運因素。

技術突破、軟體主導的工作流程和新型商業模式的整合將如何重塑醫學影像的臨床效用和採購方式

隨著影像模式設計、分析技術和部署模式的創新，醫學影像領域正經歷變革性的轉變，重新定義了影像系統在臨床實踐中的作用。電腦斷層掃描（CT）技術的進步，例如多切面和雙能量配置，正在拓展診斷能力；而磁振造影（MRI）孔徑設計和序列最佳化的進步則提高了患者的舒適度和檢查效率。同時，核醫影像技術透過PET和SPECT技術的改進，在分子診斷中發揮越來越重要的作用；超音波也透過向2D、3D/四維和多普勒技術的多元化發展，不斷拓展其床邊應用。

2025年關稅對醫療影像生態系統採購、供應鏈韌性和臨床資產管理的實際影響

2025年公佈的關稅和貿易政策變化為診斷影像供應鏈上的相關人員帶來了重大的營運和策略考量。儘管關稅是財政政策工具，但其影響卻波及採購週期、籌資策略和產品定價結構。依賴進口零件和組裝診斷影像設備的醫院和診斷中心被迫重新評估供應商和維護契約，以降低成本波動並維持服務的連續性。

綜合細分分析揭示了模式特徵、臨床環境和部署偏好如何共同決定採購和部署優先順序。

要了解市場動態，需要對技術、終端用戶環境、應用、部署方法和通路如何相互作用並影響產品的採用和使用有深入的了解。就技術而言，該領域涵蓋電腦斷層掃描 (CT)，其子類別包括雙能量 CT、多切面CT 和單切片電腦斷層掃描器。磁振造影(MRI) 涵蓋封閉式和開放式系統，而核子醫學掃描術診斷則以 PET 和 SPECT 為代表。超音波平台涵蓋2D、3D/四維和多普勒功能，X 光解決方案包括電腦放射成像、數位放射線攝影和透視。每種成像方式都有其獨特的資本投資、培訓和維護方面的考慮因素，這些因素會影響設備的部署地點和方式。

區域趨勢和營運需要正在影響全球醫療保健市場的模式採用、服務模式和市場推廣客製化。

區域趨勢仍然是策略規劃的決定性因素，法規結構、報銷模式和基礎設施成熟度的差異影響著美洲、歐洲、中東和非洲以及亞太地區的採用模式。在美洲，大規模綜合醫療系統的存在和強勁的私營部門投資通常會加速先進技術和企業級影像解決方案的採用，而採購流程則側重於總體擁有成本以及與現有臨床IT系統的互通性。

透過整合硬體、軟體訂閱和卓越服務實現差異化競爭優勢，有助於建立長期客戶關係並獲得持續收入。

市場參與企業不再僅僅依賴硬體效能，而是透過整合產品組合、卓越的售後服務和軟體賦能的價值提案來實現差異化競爭。領先的製造商將診斷成像硬體與先進的視覺化套件、基於雲端的影像管理和分析訂閱服務相結合，以拓展除一次性設備銷售之外的收入來源。從遙測預測性維護到快速回應的現場支援協議，服務產品正成為決定客戶長期滿意度和合約續約率的關鍵因素。

制定可執行的策略重點，以提高供應鏈韌性、臨床整合和商業性柔軟性，從而加速產品推廣並維持成長。

為了應對當前複雜的市場環境，產業領導者應優先採取策略行動，提高供應鏈韌性、臨床相關性和商業性柔軟性。首先，加強供應鏈透明度，建立雙源採購和近岸外包模式，將有助於降低貿易政策變化帶來的風險，並減少前置作業時間波動。投資於組件標準化和模組化系統結構，將有助於實現更靈活的採購，同時支援經濟高效的現場升級。

嚴謹的混合方法整合了關鍵相關人員的見解、臨床文獻和營運案例研究，以確保基於證據的分析。

本分析的調查方法結合了定性專家訪談、與關鍵相關人員的直接對話以及對二級資訊來源的三角驗證，從而得出關於當前醫療影像設備組件市場狀況的可靠且基於證據的觀點。關鍵資訊來源包括與臨床醫生、生物醫學工程師、採購專業人員和通路負責人的結構化討論，以深入了解現場營運挑戰和不斷變化的採購標準。這些對話為不同醫療機構的技術偏好、服務期望和採用障礙提供了背景資訊。

一項統一的策略要務，強調臨床協調、服務韌性和數位化應用是長期成功的決定因素。

結論部分綜合分析了從各種技術趨勢、市場動態和營運策略中湧現的關鍵主題。醫療影像設備相關人員必須在一個以特定模式創新、軟體和分析功能日益增強以及受貿易政策和區域差異影響的日益複雜的採購環境為特徵的環境中運作。成功的關鍵在於使產品藍圖與臨床工作流程保持一致，投資於服務能力以最大限度地減少停機時間，並提供能夠滿足不同買家需求的靈活商業模式。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 按技術分類的醫用MIM組件市場

  • 電腦斷層掃描（CT）
    • 雙能量CT
    • 多切面CT
    • 單切片電腦斷層掃描器
  • 磁振造影
    • 封閉式磁振造影
    • 開放式磁振造影
  • 核子醫學掃描術診斷
    • PET
    • SPECT
  • 超音波
    • 2D超音波
    • 3D/4D超音波
    • 多普勒超音波
  • X光
    • 電腦放射成像
    • 數位放射線攝影
    • 透視

第9章 依部署模式分類的醫療器材MIM部件市場

  • 雲
    • 混合雲端
    • 私有雲端
    • 公共雲端
  • 本地部署

第10章 按最終用戶分類的醫療器材MIM部件市場

  • 門診治療中心
  • 診斷中心
  • 居家醫療
  • 醫院
  • 研究所

第11章 按應用領域分類的醫療器材MIM零件市場

  • 疾病診斷
  • 影像導引治療
  • 預防性篩檢
  • 研究
  • 治療監測

第12章 醫療器材MIM部件市場（依分銷管道分類）

  • 直銷
  • 經銷商
    • 電子商務平台
    • OEM分銷
    • 第三方經銷商
  • 線上銷售

第13章 區域性醫療器材MIM零件市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 醫療器材MIM零件市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國醫療器材MIM零件市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國醫療器材MIM組件市場

第17章：中國醫療器材MIM零件市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ACI Alloys, LLC
  • ARC Group Worldwide PLC
  • Dean Group International
  • Form Technologies, Inc.
  • GKN Powder Metallurgy Limited
  • Indo-MIM Private Limited
  • MIM Holding GmbH
  • Nippon Gijutsu Toseki Co., Ltd.
  • PyroGenesis Canada Inc.
  • Seiko Epson Corporation
  • Shanghai Melty MIM Technology Co., Ltd.
  • Sumitomo Electric Industries, Ltd.
Product Code: MRR-4F7A6D4FF371

The Medical MIM Component Market was valued at USD 4.17 billion in 2025 and is projected to grow to USD 4.44 billion in 2026, with a CAGR of 6.45%, reaching USD 6.46 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.17 billion
Estimated Year [2026] USD 4.44 billion
Forecast Year [2032] USD 6.46 billion
CAGR (%) 6.45%

Concise orientation to the evolving medical imaging components landscape that frames clinical, technological, and procurement drivers shaping strategic decisions

The medical imaging component landscape is experiencing rapid evolution driven by parallel advances in hardware design, software analytics, and care delivery models. This report opens with a concise orientation that frames the current environment, highlighting how modality diversification, interoperability priorities, and shifting end-user demands converge to reshape procurement and clinical workflows. By situating the reader within this dynamic context, the introduction clarifies the technological and operational levers that most influence adoption and investment decisions.

Clinicians and health system leaders increasingly evaluate imaging assets not only on image quality and uptime but also on data integration, lifecycle service models, and total cost of ownership. Therefore, introducing the topic with an emphasis on multi-stakeholder value-radiology teams, IT departments, biomedical engineering, and procurement-helps to align subsequent insights to practical decision criteria. The framing also emphasizes the interplay between modality capability and application focus, such as how CT and MRI enhancements affect diagnostic throughput and therapeutic planning.

Finally, the introduction previews methodological rigor and the structure of analysis used throughout the report, reinforcing that conclusions are grounded in an integrative review of clinical literature, regulatory trends, procurement patterns, and supply chain observations. This grounding equips readers with a clear line of sight into what the analysis will and will not address, thereby setting realistic expectations for actionable takeaways.

How converging technological breakthroughs, software-driven workflows, and new commercial models are reshaping clinical utility and procurement approaches in medical imaging

The medical imaging landscape is undergoing transformative shifts as innovation in modality design, analytics, and deployment models redefines what imaging systems can deliver in clinical settings. Advances in computed tomography such as multi-slice and dual-energy architectures are expanding diagnostic capabilities, while magnetic resonance developments in bore design and sequence optimization are improving patient comfort and throughput. Concurrently, nuclear imaging continues to deepen its role in molecular diagnostics with PET and SPECT refinements, and ultrasound diversification across 2D, 3D/4D, and Doppler techniques broadens point-of-care applicability.

At the same time, software-defined imaging and AI-driven analytics are moving from experimental pilots to embedded workflow tools, enabling faster interpretation and decision support. Cloud-enabled deployment and hybrid on-premises arrangements are accelerating data mobility and collaborative diagnostics across hospitals, diagnostic centers, and ambulatory care sites. Distribution channels are also shifting; direct sales relationships coexist with distributor networks that leverage e-commerce platforms and third-party partners to reach diverse end users, including growing homecare use cases.

These shifts are accompanied by service model innovations where vendors bundle equipment with subscription-based software, analytics, and managed services to reduce upfront capital barriers and align incentives toward uptime and clinical performance. Collectively, these developments create a market environment where interoperability, clinical utility, and flexible commercial models increasingly determine long-term adoption.

Practical implications of 2025 tariff actions on procurement, supply chain resilience, and clinical asset management across the medical imaging ecosystem

The introduction of tariffs and trade policy changes announced in 2025 have created a consequential set of operational and strategic considerations for stakeholders across the imaging supply chain. While tariffs are a fiscal policy tool, their practical effects propagate through procurement cycles, sourcing strategies, and product pricing structures. Hospitals and diagnostic centers that rely on imported components or fully assembled imaging systems have had to revisit supplier contracts and maintenance agreements to mitigate cost volatility and preserve service continuity.

In response, procurement teams have accelerated dual-sourcing strategies and regional supplier development to reduce dependency on single origins of supply. Original equipment manufacturers and subsystem suppliers have evaluated localized production, component redesign, and bill-of-material substitutions to manage exposure to tariff bands. At the same time, distributors and channel partners have adapted inventory policies to smooth cost pass-through and maintain competitive bid positioning for end users.

Clinically, payers and health systems have assessed the downstream impact of incremental equipment costs on capital budgeting and upgrade cycles, often prioritizing modular upgrades and software enhancements over full system replacements to sustain diagnostic capabilities. Regulatory and compliance functions have also been engaged to ensure that any supply chain adjustments-such as component substitutions or new manufacturing sites-meet safety and performance standards. Ultimately, the tariff environment has underscored the importance of supply chain visibility, contractual flexibility, and scenario planning for imaging stakeholders.

Integrated segmentation analysis highlighting how modality specifics, care settings, and deployment choices collectively determine procurement and deployment priorities

Understanding market dynamics requires a nuanced view of how technology, end-user settings, applications, deployment choices, and distribution pathways interact to shape adoption and use. By technology, the landscape encompasses computed tomography, with subcategories including dual-energy CT, multi-slice CT, and single-slice CT; magnetic resonance imaging, spanning closed bore and open bore systems; nuclear imaging, represented by PET and SPECT modalities; ultrasound platforms covering 2D, 3D/4D, and Doppler capabilities; and X-ray solutions that include computed radiography, digital radiography, and fluoroscopy. Each modality segment presents distinct capital, training, and maintenance considerations that influence where and how devices are deployed.

Examining end users reveals divergent needs across ambulatory care centers, diagnostic centers, homecare, hospitals, and research institutes. Hospitals typically demand high-throughput, enterprise-grade systems that integrate with electronic health records and PACS, whereas ambulatory and homecare settings prioritize compact form factors, ease of use, and rapid serviceability. Application-focused segmentation shows that disease diagnosis, image-guided interventions, preventive screening, research, and therapeutic monitoring each drive different modality preferences and accessory ecosystems, shaping purchase criteria and aftermarket service requirements.

Deployment mode considerations-cloud versus on-premises, including hybrid, private, and public cloud models-affect data governance, interoperability, and remote collaboration. Distribution channels vary from direct sales to distributors and online sales; within distributor networks, differences emerge between e-commerce platforms, OEM distribution, and third-party distributors. These interlocking dimensions guide competitive positioning, product roadmaps, and commercialization strategies.

Regional dynamics and operational imperatives that determine modality adoption, service models, and go-to-market customization across global healthcare markets

Regional dynamics continue to be a decisive factor in strategic planning, with variations in regulatory frameworks, reimbursement models, and infrastructure maturity shaping adoption patterns across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, the presence of large integrated health systems and strong private-sector investment typically accelerates uptake of advanced modalities and enterprise imaging solutions, while procurement processes emphasize total cost of ownership and interoperability with established clinical IT systems.

Across Europe, Middle East & Africa, heterogeneous regulatory landscapes and mixed public-private funding models require vendors to adopt flexible commercial strategies and localized service footprints. Governments and large provider networks in certain countries prioritize preventive screening programs and population health integration, which can create demand for portable imaging and cloud-enabled analytics. In the Asia-Pacific region, rapid infrastructure expansion, growing diagnostic volumes, and increasing investment in research institutions drive diverse opportunities for both high-end modalities and scalable ultrasound and X-ray solutions tailored for high-throughput environments.

Transitioning across regions often necessitates adapting product specifications, training programs, and financing arrangements to meet local clinical protocols and budgetary constraints. Therefore, regional go-to-market strategies must balance global platform standardization with localized customization to optimize both clinical adoption and operational sustainability.

Competitive differentiation through integrated hardware, software subscriptions, and service excellence that sustain long-term customer relationships and recurring revenue

Market participants are differentiating on the basis of integrated portfolios, aftermarket service excellence, and software-enabled value propositions rather than purely on hardware capabilities. Leading manufacturers increasingly pair imaging hardware with advanced visualization suites, cloud-based image management, and analytics subscriptions to extend revenue streams beyond one-time equipment sales. Service offerings-ranging from predictive maintenance enabled by telemetry to rapid field support contracts-have become critical determinants of long-term customer satisfaction and renewal rates.

Channel partners and distributors are investing in digital commerce and logistics capabilities to shorten lead times and improve transparency around spare parts and consumables. Strategic partnerships between hardware vendors, independent software developers, and healthcare IT firms are also producing interoperable ecosystems that facilitate seamless data flow into enterprise clinical workflows. Research institutions and specialized clinical centers are driving early adoption of novel imaging protocols and adjunct software, which helps to validate clinical utility and accelerate broader commercialization.

In procurement interactions, buyers increasingly evaluate vendor stability, roadmap clarity, and the ability to support lifecycle upgrades. Firms that demonstrate strong compliance track records, robust quality systems, and scalable global service networks are positioned to capture long-term relationships with large health systems, diagnostic chains, and research consortia. Overall, sustainable competitive advantage is migrating toward combined strengths in clinical validation, service delivery, and digital enablement.

Actionable strategic priorities that enhance supply resilience, clinical integration, and commercial flexibility to accelerate adoption and sustain growth

Industry leaders should prioritize strategic actions that enhance supply resilience, clinical relevance, and commercial flexibility to navigate current market complexities. First, strengthening supply chain transparency and establishing dual-sourcing or nearshoring options will mitigate exposure to trade policy shifts and reduce lead-time volatility. Investing in component standardization and modular system architectures enables more agile sourcing while supporting cost-effective field upgrades.

Second, accelerating integration of analytics and workflow automation into imaging platforms can materially improve clinical throughput and decision support, which in turn strengthens the value proposition for buyers. Vendors should invest in validated AI tools, clear performance metrics, and clinician-focused user experience design to drive adoption. Third, evolving commercial models toward outcome-linked and subscription-based structures can lower entry barriers for providers while creating predictable recurring revenue streams for suppliers.

Fourth, regional go-to-market strategies must combine global product consistency with localized service, training, and financing solutions to match differing procurement cycles and regulatory requirements. Finally, organizations should expand cross-sector partnerships-linking vendors, payers, and research institutions-to co-develop evidence that demonstrates clinical and economic value, thereby accelerating reimbursement pathways and clinical integration.

Rigorous mixed-methods approach combining primary stakeholder insights, clinical literature, and operational case studies to ensure evidence-based analysis

The research methodology underpinning this analysis combines qualitative expert interviews, primary stakeholder engagements, and secondary source triangulation to produce a robust, evidence-informed view of the medical imaging components landscape. Primary inputs included structured discussions with clinicians, biomedical engineers, procurement officers, and channel partners to capture firsthand operational challenges and evolving procurement criteria. These engagements provided context on technology preferences, service expectations, and adoption barriers across different care settings.

Secondary research encompassed peer-reviewed clinical literature, regulatory guidance, and publicly available industry documentation to validate technical performance characteristics and compliance trends. Market intelligence was cross-referenced with case studies on deployment outcomes and supply chain adjustments, ensuring that observations reflect real-world implementations rather than theoretical possibilities. The analysis emphasized transparency in assumptions and differentiated between observed trends and projected scenarios.

Finally, synthesis involved iterative validation with domain experts to refine interpretations and ensure that conclusions accurately represent prevailing clinical, operational, and commercial realities. This mixed-methods approach supports a balanced representation of technical detail and strategic relevance for decision-makers.

Synthesis of strategic imperatives emphasizing clinical alignment, service resilience, and digital enablement as determinants of long-term success

The conclusion synthesizes the key themes that emerged across technology, market dynamics, and operational strategy. Medical imaging component stakeholders must navigate a landscape characterized by modality-specific innovation, the expanding role of software and analytics, and an increasingly complex procurement environment influenced by trade policy and regional variability. Success hinges on aligning product roadmaps with clinical workflows, investing in service capabilities that minimize downtime, and offering flexible commercial models that address diverse buyer constraints.

Moreover, resilience in supply chains and clarity around regulatory compliance will continue to be decisive factors as geopolitical and economic policy shifts create episodic disruption. Vendors that successfully integrate digital capabilities, demonstrate clinical value through evidence generation, and cultivate localized service networks will be best positioned to capture sustained adoption across hospitals, diagnostic centers, ambulatory settings, and research institutions.

In sum, the sector is moving toward solutions that deliver not only image fidelity but also actionable data, reliable service, and commercial models that reduce barriers to procurement. Stakeholders who proactively adapt across these dimensions will secure strategic advantage in a rapidly evolving healthcare landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical MIM Component Market, by Technology

  • 8.1. Computed Tomography
    • 8.1.1. Dual-Energy Ct
    • 8.1.2. Multi-Slice Ct
    • 8.1.3. Single-Slice Ct
  • 8.2. Magnetic Resonance Imaging
    • 8.2.1. Closed Bore Mri
    • 8.2.2. Open Bore Mri
  • 8.3. Nuclear Imaging
    • 8.3.1. Pet
    • 8.3.2. Spect
  • 8.4. Ultrasound
    • 8.4.1. 2D Ultrasound
    • 8.4.2. 3D/4D Ultrasound
    • 8.4.3. Doppler Ultrasound
  • 8.5. X-Ray
    • 8.5.1. Computed Radiography
    • 8.5.2. Digital Radiography
    • 8.5.3. Fluoroscopy

9. Medical MIM Component Market, by Deployment Mode

  • 9.1. Cloud
    • 9.1.1. Hybrid Cloud
    • 9.1.2. Private Cloud
    • 9.1.3. Public Cloud
  • 9.2. On-Premises

10. Medical MIM Component Market, by End User

  • 10.1. Ambulatory Care Centers
  • 10.2. Diagnostic Centers
  • 10.3. Homecare
  • 10.4. Hospitals
  • 10.5. Research Institutes

11. Medical MIM Component Market, by Application

  • 11.1. Disease Diagnosis
  • 11.2. Image-Guided Interventions
  • 11.3. Preventive Screening
  • 11.4. Research
  • 11.5. Therapeutic Monitoring

12. Medical MIM Component Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
    • 12.2.1. E-Commerce Platforms
    • 12.2.2. Oem Distribution
    • 12.2.3. Third-Party Distributors
  • 12.3. Online Sales

13. Medical MIM Component Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical MIM Component Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical MIM Component Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical MIM Component Market

17. China Medical MIM Component Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ACI Alloys, LLC
  • 18.6. ARC Group Worldwide PLC
  • 18.7. Dean Group International
  • 18.8. Form Technologies, Inc.
  • 18.9. GKN Powder Metallurgy Limited
  • 18.10. Indo-MIM Private Limited
  • 18.11. MIM Holding GmbH
  • 18.12. Nippon Gijutsu Toseki Co., Ltd.
  • 18.13. PyroGenesis Canada Inc.
  • 18.14. Seiko Epson Corporation
  • 18.15. Shanghai Melty MIM Technology Co., Ltd.
  • 18.16. Sumitomo Electric Industries, Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL MIM COMPONENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL MIM COMPONENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MEDICAL MIM COMPONENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DUAL-ENERGY CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DUAL-ENERGY CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DUAL-ENERGY CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY MULTI-SLICE CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY MULTI-SLICE CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY MULTI-SLICE CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY SINGLE-SLICE CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY SINGLE-SLICE CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY SINGLE-SLICE CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY CLOSED BORE MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY CLOSED BORE MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY CLOSED BORE MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY OPEN BORE MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY OPEN BORE MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY OPEN BORE MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY SPECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY SPECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY SPECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY 2D ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY 2D ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY 2D ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY 3D/4D ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY 3D/4D ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY 3D/4D ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DOPPLER ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DOPPLER ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DOPPLER ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY FLUOROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY FLUOROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY FLUOROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY HYBRID CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY HYBRID CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PRIVATE CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PRIVATE CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PUBLIC CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PUBLIC CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ON-PREMISES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ON-PREMISES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DISEASE DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DISEASE DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY IMAGE-GUIDED INTERVENTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY IMAGE-GUIDED INTERVENTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY IMAGE-GUIDED INTERVENTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PREVENTIVE SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PREVENTIVE SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PREVENTIVE SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY THERAPEUTIC MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY THERAPEUTIC MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY OEM DISTRIBUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY OEM DISTRIBUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY OEM DISTRIBUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 250. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 253. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 254. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 255. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 256. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 257. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 258. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 259. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 289. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 290. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 291. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 292. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 293. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 294. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 295. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 296. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 297. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 298. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 300. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 301. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 302. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 303. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 304. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 305. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 306. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 307. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 308. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 309. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 310. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 311. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 312. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 313. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 314. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 315. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILL